PH DEPENDENCY OF THE BINDING OF [H-3] BAY-U-3405 AND VARIOUS NON-LABELED LIGANDS TO THE THROMBOXANE-A2/PROSTAGLANDIN H-2-RECEPTOR OF HUMAN PLATELET MEMBRANES

被引:2
作者
THEIS, JGW
DELLWEG, H
PERZBORN, E
GROSS, R
机构
[1] BAYER AG,DEPT PHARMACOL,W-5600 WUPPERTAL 1,GERMANY
[2] BAYER AG,DEPT BIOCHEM,W-5600 WUPPERTAL 1,GERMANY
来源
EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION | 1992年 / 226卷 / 02期
关键词
THROMBOXANE-A2; THROMBOXANE-A2 RECEPTOR ANTAGONIST; THROMBOXANE-A2 RECEPTOR AGONIST; PH DEPENDENCY; RADIOLIGAND BINDING; PLATELET MEMBRANES (HUMAN); BAY-U-3405;
D O I
10.1016/0922-4106(92)90176-V
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
[H-3]BAY U 3405 was used to characterize the effect of acidic and alkaline pH values on the binding of the thromboxane A2/prostaglandin H-2 (TXA2/PGH2) receptor of human platelet membranes. The specific binding of [H-3]BAY U 3405 largely increased upon acidification up to pH 5.8. Saturation binding studies revealed an increase in binding affinity without change in the number of binding sites. At pH 7.4 the K(d) was 8.7 +/- 3.7 nM (B(max) = 6.6 +/- 0.6 pmol/mg protein) compared to 1.2 +/- 0.2 nM (B(max) = 6.1 +/- 0.6 pmol/mg protein) at pH 5.8. A more than 10-fold higher rate of association was observed at pH 5.8 compared to pH 7.4, while the rate of dissociation showed only minor changes. The kinetically derived dissociation constant was 1 nM (pH 5.8) and 9.6 nM (pH 7.4). The pH dependency of the binding of structurally different non-labelled ligands to the TXA2/PGH2 receptor was evaluated by inhibition studies at pH 5.8 and pH 7.4. BAY U 3405, daltroban, CTA2, and U 46619 showed significantly higher affinities at pH 5.8. In contrast, I-PTA-OH and GR 32191 had a higher affinity at pH 7.4. No significant difference was seen with SQ 29548 at the observed pH values. A second protonable group within the molecules I-PTA-OH, GR 32191, and SQ 29548 might be responsible for the observed differences.
引用
收藏
页码:149 / 156
页数:8
相关论文
共 25 条
  • [1] BARBER AJ, 1970, J BIOL CHEM, V245, P6357
  • [2] BILLAHMM, 1980, J BIOL CHEM, V255, P10227
  • [3] FITZGERALD GA, 1987, FASEB J, V46, P154
  • [4] THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES
    HAMBERG, M
    SVENSSON, J
    SAMUELSSON, B
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) : 2994 - 2998
  • [5] CHARACTERIZATION OF THROMBOXANE A2 PROSTAGLANDIN H-2 (TXA2/PGH2) RECEPTORS OF RAT PLATELETS AND THEIR INTERACTION WITH TXA2/PGH2 RECEPTOR ANTAGONISTS
    HANASAKI, K
    ARITA, H
    [J]. BIOCHEMICAL PHARMACOLOGY, 1988, 37 (20) : 3923 - 3929
  • [6] CLONING AND EXPRESSION OF CDNA FOR A HUMAN THROMBOXANE-A2 RECEPTOR
    HIRATA, M
    HAYASHI, Y
    USHIKUBI, F
    YOKOTA, Y
    KAGEYAMA, R
    NAKANISHI, S
    NARUMIYA, S
    [J]. NATURE, 1991, 349 (6310) : 617 - 620
  • [7] EFFECT OF CYTOPLASMIC PH ON PLATELET ACTIVATION BY ARACHIDONIC-ACID
    ISHIKAWA, Y
    OGAWA, A
    SASAKAWA, S
    [J]. THROMBOSIS RESEARCH, 1989, 54 (01) : 17 - 26
  • [8] KERRY PJ, 1984, BRIT J PHARMACOL, V81, P125, DOI 10.1111/j.1476-5381.1984.tb10752.x
  • [9] THE PH DEPENDENT PLATELET UTILIZATION OF ARACHIDONIC-ACID AND A THROMBOXANE-A2 MIMETIC, INVITRO
    KERRY, PJ
    PATON, CJ
    [J]. PHARMACOLOGICAL RESEARCH COMMUNICATIONS, 1985, 17 (07): : 609 - 618
  • [10] LEFER AM, 1985, FED PROC, V44, P275